Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 28, 2022

SELL
$54.9 - $105.21 $534,561 - $1.02 Million
-9,737 Closed
0 $0
Q3 2021

Oct 14, 2021

BUY
$105.0 - $178.37 $1.02 Million - $1.74 Million
9,737 New
9,737 $1.03 Million
Q4 2019

Jan 31, 2020

SELL
$29.79 - $43.06 $732,625 - $1.06 Million
-24,593 Closed
0 $0
Q3 2019

Nov 13, 2019

BUY
$30.47 - $37.65 $749,348 - $925,926
24,593 New
24,593 $796,000

Others Institutions Holding ZLAB

About Zai Lab Ltd


  • Ticker ZLAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,908,704
  • Market Cap $2.96B
  • Description
  • Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...
More about ZLAB
Track This Portfolio

Track Hamilton Lane Advisors LLC Portfolio

Follow Hamilton Lane Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hamilton Lane Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hamilton Lane Advisors LLC with notifications on news.